Cadila
Cadila scores FDA approval for BMS and Alvogen generics
July 3, 2018Manufacturing and Production, Sales and Marketing Adolat, Alvogen, Bristol-Myers Squibb, Cadila, FDA, Questran, generics, pharma
Cadila Healthcare has announced that it has gained FDA final approval to market nifedipine ER tablets in the strengths of …
Cadila and Supernus settle patent dispute over epilepsy generic
March 7, 2017Manufacturing and Production, Sales and Marketing Cadila, Supernus, Trokendi XR, Zydus Cadila
A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus Pharmaceuticals has been ended with legal calls for …
Cadila plant in India gets FDA warning
July 11, 2011Manufacturing and Production Cadila, FDA warning letter, pharma manufacturing news
Indian drugmaker Cadila Healthcare has been taken to task by the US FDA for quality violations at a new sterile …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
September 25, 2026
One in three UK women with migraine say symptoms taken less seriously
September 24, 2026
Report highlights scope to expand day surgery
September 23, 2026
Sygnature formalises drug discovery collaboration with X-Chem
September 22, 2026
Codis appoints Steven Facer as chief commercial officer
September 21, 2026
